IMRX
#3229
Immuneering Corporation - Class A Common Stock
5.2 1 USD
+0.01%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.97%
Changement Mensuel
+24.34%
Evolution sur 6 mois
+12.77%
Changement Annuel
+28.33%
Clôture Précédente
5.1 6
Open
5.2 1
Low
5.2 1
High
5.2 1
Volume
73
Financials
- Market Capitalization 337.07 M
- Employee 55
- Founded 2008
- CEO N/A
- Website www.immuneering.com
- Headquarter Delaware, United States
- FIGI BBG009QXJQS1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3217 |  HELP Cybin Inc. - Common Stock | 6.68 USD | -0.30% | +13.03% | +56.81% | -25.53% | 344.90 M USD | ||
| 3225 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 4.77 USD | +3.25% | 0.00% | +26.86% | +253.33% | 339.56 M USD | ||
| 3230 |  CTNM Contineum Therapeutics, Inc. - Common stock | 14.57 USD | -0.34% | -0.27% | +15.00% | -4.58% | 336.55 M USD | ||
| 3232 |  PALI Palisade Bio, Inc. - Common Stock | 1.93 USD | +2.12% | -5.85% | +14.88% | +13.53% | 335.01 M USD |